官方服务：
资源简介：
All TEAEs >10%–safety population.
应用场景：
创建时间：
2018-10-10
相关数据集
Number (%) of Subjects with Adverse Events During Days 1 to 28.
Note: *Determined by the investigator to be possibly or probably related to the study vaccine.
NIAID Data Ecosystem50
Prior and Concomitant Medications and Systemic Antimicrobials in Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants <750 Grams Birth Weight
Prior and Concomitant Medications and Systemic Antimicrobials Dataset Study Description This was a prospective, randomized, double-blind, multi-center, efficacy study comparing fluconazole prophylaxis
NIAID Data Ecosystem50
Patient incidence of treatment-emergent gastrointestinal bleeding events with historic control (EVOLVE).
Patient incidence of treatment-emergent gastrointestinal bleeding events with historic control (EVOLVE).
Figshare2019-03-15 更新10
Megadoses and mortality (multivariate analysis adjusted according to patient age, comorbidities and other treatments).
Megadoses and mortality (multivariate analysis adjusted according to patient age, comorbidities and other treatments).
NIAID Data Ecosystem50
Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide
In order to evaluate the main adverse effects of drug protocols using bortezomib and/or thalidomide for the treatment of multiple myeloma, we conducted a prospective study. Data were collected through
NIAID Data Ecosystem20
